These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19444133)

  • 21. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restenosis in coronary bare metal stents. Importance of time to follow-up: a comparison of coronary angiograms 6 months and 4 years after implantation.
    Jørgensen E; Helqvist S; Kløvgaard L; Kastrup J; Clemmensen P; Holmvang L; Engstrøm T; Saunamaki K; Kelbaek H
    Scand Cardiovasc J; 2009 Apr; 43(2):87-93. PubMed ID: 19031301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute coronary syndrome due to hinge movement of a bare-metal stent.
    Yagi S; Kimura T; Hayashi I; Nishiuchi T
    Int J Cardiol; 2008 Jan; 123(3):e64-6. PubMed ID: 17335922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of restenosis in drug eluting stents: new insights from greyscale intravascular ultrasound and virtual histology.
    Garcia-Garcia HM; Shen Z; Piazza N
    EuroIntervention; 2009 May; 5 Suppl D():D84-92. PubMed ID: 19736078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima.
    Yokoyama S; Takano M; Yamamoto M; Inami S; Sakai S; Okamatsu K; Okuni S; Seimiya K; Murakami D; Ohba T; Uemura R; Seino Y; Hata N; Mizuno K
    Circ Cardiovasc Interv; 2009 Jun; 2(3):205-12. PubMed ID: 20031717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies.
    Steinberg DH; Mintz GS; Mandinov L; Yu A; Ellis SG; Grube E; Dawkins KD; Ormiston J; Turco MA; Stone GW; Weissman NJ
    JACC Cardiovasc Interv; 2010 May; 3(5):486-94. PubMed ID: 20488404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
    Hasegawa T; Ako J; Koo BK; Miyazawa A; Sakurai R; Chang H; Dens J; Verheye S; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):34-41. PubMed ID: 19089934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IVUS rings mapping a patient's history.
    Sgueglia GA; Todaro D; Conte M; Stipo A; Pucci E
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):817-8. PubMed ID: 21934522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial.
    Miyazawa A; Ako J; Hassan A; Hasegawa T; Abizaid A; Verheye S; McClean D; Neumann FJ; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):952-7. PubMed ID: 18044777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unprotected left main bifurcation restenosis treated with a 2-stent technique.
    Wainstein MV; Wainstein RV; Ribeiro JP
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E200-5. PubMed ID: 22972629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance.
    Yoshida O; Hirayama H; Nanasato M; Watanabe T; Murohara T
    Am Heart J; 2005 Jan; 149(1):e2. PubMed ID: 15660025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High energy excimer laser to treat coronary in-stent restenosis in an underexpanded stent.
    Noble S; Bilodeau L
    Catheter Cardiovasc Interv; 2008 May; 71(6):803-7. PubMed ID: 18324694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy.
    Cilingiroglu M; Chilakapati V; Dunlap S; Leesar MA
    Cardiovasc Revasc Med; 2010; 11(2):120-3. PubMed ID: 20347805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
    Aoki J; Mintz GS; Weissman NJ; Mann JT; Cannon L; Greenberg J; Grube E; Masud AR; Koglin J; Mandinov L; Stone GW
    JACC Cardiovasc Interv; 2008 Apr; 1(2):161-7. PubMed ID: 19463294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stent fracture: an unusual cause of late restenosis after sirolimus-eluting stent placement.
    Mehrle A; Skelton T; Almonacid A
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):988-91. PubMed ID: 17191207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.